Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 70%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is a solid investment choice, as evidenced by their strong balance sheet, low leverage, and ample liquidity. With a strong investment outlook and a diverse portfolio of healthcare-related real estate assets, the company is well-positioned to drive incremental growth and achieve high returns on their investments. While there are potential risks such as changes in the regulatory environment, the company's aggressive deployment of capital and strong tenant relationships provide a buffer against these risks. Additionally, the company's focus on ESG priorities and its commitment to responsible corporate conduct are positive factors that further enhance its investment potential. Based on a target multiple of 7x, the target price for CTRE is currently at $44 per share, supporting an Outperform rating.

Bears say

CareTrust REIT is a healthcare REIT that primarily invests in skilled nursing facilities and seniors housing communities. However, the company has a negative outlook due to increasing competition and high private market valuations for these property segments, which could limit the company's ability to acquire new properties. Additionally, the recent entry into the SHOP asset class may provide potential for organic growth, but the current supply/demand mismatch and lack of development in this sector may not provide long-term sustainable growth.

CareTrust REIT (CTRE) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 70% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 10 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Jul 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.